Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
A population-based study comparing multiple sclerosis clinic users and non-users in British Columbia, Canada.
Genetic variation associated with the occurrence and progression of neurological disorders.
Enlargement of cerebral ventricles as an early indicator of encephalomyelitis.
Requirement for safety monitoring for approved MS therapies - An overview.
Activation of MSRV-Type Endogenous Retroviruses during Infectious Mononucleosis and Epstein-Barr Virus Latency: The Missing Link with Multiple Sclerosis?
Matrine regulates glutamate-related excitotoxic factors in experimental autoimmune encephalomyelitis.
Identification of Tmem10 as a Novel Late-stage Oligodendrocytes Marker for Detecting Hypomyelination.
A non-synonymous single-nucleotide polymorphism associated with multiple sclerosis risk affects the EVI5 interactome.
[Future issues of the multiple sclerosis treatment from a medical economic viewpoint].
Reversed takotsubo cardiomyopathy in a patient with new-onset multiple sclerosis: Cause, link, or just coincidence?
Orofaryngeale slikstoornissen bij neurodegeneratieve aandoeningen.
Rituximab as a first-line preventive treatment in pediatric NMOSDs: Preliminary results in 5 children.
Induction of oligodendrocyte differentiation and in vitro myelination by inhibition of rho-associated kinase.
Frequency of Blood-tissue Parasitic Infections in Patients with Multiple Sclerosis, as Compared to their Family Members.
Applications of optical coherence tomography in pediatric clinical neuroscience.
The Neurocognitive Profile of the Cerebellum in Multiple Sclerosis.
An update of teriflunomide for treatment of multiple sclerosis.
Full-Length and Fragmented Netrin-1 in Multiple Sclerosis Plaques Are Inhibitors of Oligodendrocyte Precursor Cell Migration.
A blood based 12-miRNA signature of Alzheimer disease patients.
Cognitive processing speed has minimal influence on the construct validity of Multiple Sclerosis Walking Scale-12 scores.
Acute-Phase Protein Hemopexin Is a Negative Regulator of Th17 Response and Experimental Autoimmune Encephalomyelitis Development.
P2X4 receptors control the fate and survival of activated microglia.
Distinction of seropositive NMO spectrum disorder and MS brain lesion distribution.
Fingolimod: A Review of Its Use in Relapsing-Remitting Multiple Sclerosis.
Neurology of inherited glycosylation disorders.
Pages
« first
‹ previous
…
639
640
641
642
643
644
645
646
647
…
next ›
last »